Blunted fasting-induced hypothalamic activation and refeeding hyperphagia in late-onset obesity

Neuroendocrinology

Volumn 90, Issue 4, 2009, Pages 371-382

  Becskei, Csilla ^a   Lutz, Thomas A ^a   Riediger, Thomas ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Arcuate nucleus, hypothalamic; C Fos; Hypothalamic area, lateral; Obesity, late onset; Paraventricular nucleus, hypothalamic

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; MELANIN CONCENTRATING HORMONE; NEUROPEPTIDE Y; OREXIN; PROTEIN C FOS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; ENERGY BALANCE; FEEDING BEHAVIOR; GLUCOSE BLOOD LEVEL; HYPERINSULINEMIA; HYPERLEPTINEMIA; HYPERPHAGIA; HYPOGLYCEMIA; HYPOTHALAMUS; HYPOTHALAMUS NUCLEUS; LEAN BODY WEIGHT; MALE; MOUSE; NERVE CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REFEEDING; THALAMUS MIDLINE NUCLEUS;

AGE OF ONSET; ANIMALS; ARCUATE NUCLEUS; BLOOD GLUCOSE; FASTING; GREEN FLUORESCENT PROTEINS; HYPERINSULINISM; HYPERPHAGIA; HYPOTHALAMIC AREA, LATERAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; MELANINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; NEUROPEPTIDE Y; NEUROPEPTIDES; OBESITY; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PROTO-ONCOGENE PROTEINS C-FOS;

EID: 71849098260     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000251723     Document Type: Article

References (35)

1. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG: Central nervous system control of food intake. Nature 2000; 404: 661-671.
2. Morikawa Y, Ueyama E, Senba E: Fasting-induced activation of mitogen-activated protein kinases (ERK/p38) in the mouse hypothalamus. J Neuroendocrinol 2004; 16: 105-112.
3. Ueyama E, Morikawa Y, Yasuda T, Senba E: Attenuation of fasting-induced phosphorylation of mitogen-activated protein kinases (ERK/p38) in the mouse hypothalamus in response to refeeding. Neurosci Lett 2004; 371: 40-44.
4. Riediger T, Bothe C, Becskei C, Lutz TA: Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression. Neuroendocrinology 2004; 79: 317-326.
5. Becskei C, Lutz TA, Riediger T: Intraperitoneal glucose application reverses the fastinginduced c-Fos expression in the hypothalamic arcuate nucleus of mice. Neuroreport 2008; 19: 105-109.
6. Becskei C, Bilik KU, Klussmann S, Jarosch F, Lutz TA, Riediger T: The anti-ghrelin Spiegelmer NOX-B11-3 blocks ghrelin- but not fasting-induced neuronal activation in the hypothalamic arcuate nucleus. J Neuroendocrinol 2008; 20: 85-92.
7. Fioramonti X, Contie S, Song Z, Routh VH, Lorsignol A, Penicaud L: Characterization of glucosensing neuron subpopulations in the arcuate nucleus: Integration in NPY and POMC networks? Diabetes 2007; 56: 1219-1227.
8. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S: A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198.
9. Wang L, Saint-Pierre DH, Tache Y: Peripheral ghrelin selectively increases Fos expression in neuropeptide Y-synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci Lett 2002; 325: 47-51.
10. Halaas JL, Boozer C, Blair-West J: Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 1997; 94: 8878-8883.
11. Bjorntorp P: Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 1997; 13: 795-803.
12. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M: Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, doseescalation trial. JAMA 1999; 282: 1568-1575.
13. Münzberg H, Flier JS, Bjørbaek C: Regionspecific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 2004; 145: 4880-4889.
14. Enriori PJ, Evans AE, Sinnayah P, Jobst EE, Tonelli-Lemos L, Billes SK, Glavas MM, Grayson BE, Perello M, Nillni EA, Grove KL, Cowley MA: Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab 2007; 5: 181-194.
15. Levin BE, Govek EK, Dunn-Meynell AA: Reduced glucose-induced neuronal activation in the hypothalamus of diet-induced obese rats. Brain Res 1998; 808: 317-319.
16. Ryabinin AE, Wang YM, Finn DA: Different levels of Fos immunoreactivity after repeated handling and injection stress in two inbred strains of mice. Pharmacol Biochem Behav 1999; 63: 1143-1151.
17. Scarpace PJ, Zhang Y: Elevated leptin: Consequence or cause of obesity? Front Biosci 2007; 12: 3531-3544.
18. Wielinga PY, Alder B, Lutz TA: The acute effect of amylin and salmon calcitonin on energy expenditure. Physiol Behav 2007; 91: 212-217.
19. Becskei C, Riediger T, Hernadfalvy N, Arsenijevic D, Lutz TA, Langhans W: Inhibitory effects of lipopolysaccharide on hypothalamic nuclei implicated in the regulation of food intake. Brain Behav Immun 2008; 22: 56-64.
20. Hof PR, Young WG, Bloom FE, Belichenko PV, Celio MR: Comparative Cytoarchitectonic Atlas of the C57BL/6 and 129/Sv Mouse Brains. New York, Elsevier, 2001.
21. Riediger T, Zuend D, Becskei C, Lutz TA: The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis. Am J Physiol Regul Integr Comp Physiol 2004; 286:R114-R122.
22. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG: The hypocretins: Hypothalamus- specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998; 95: 322-327.
23. Skofitsch G, Jacobowitz DM, Zamir N: Immunohistochemical localization of a melanin concentrating hormone-like peptide in the rat brain. Brain Res Bull 1985; 15: 635-649.
24. Di Francesco V, Fantin F, Omizzolo F, Residori L, Bissoli L, Bosello O, Zamboni M: The anorexia of aging. Dig Dis 2007; 25: 129-137.
25. Becskei C, Lutz TA, Riediger T: Hypothalamic c-Fos expression in fasted mice decreases with obesity but not with age. Proc 10th Int Congr Obesity, Sydney, Australia, 2006.
26. Beaton JR, Feleki V, Stevenson JA: Insulin hyperphagia in rats fed a low-protein diet. Can J Physiol Pharmacol 1965; 43: 225-233.
27. Smith GP, Epstein AN: Increased feeding in response to decreased glucose utilization in the rat and monkey. Am J Physiol 1969; 217: 1083-1087.
28. Luquet S, Phillips CT, Palmiter RD: NPY/ AgRP neurons are not essential for feeding responses to glucoprivation. Peptides 2007; 28: 214-225.
29. Baskin DG, Breininger JF, Bonigut S, Miller MA: Leptin binding in the arcuate nucleus is increased during fasting. Brain Res 1999; 15: 154-158.
30. Baskin DG, Breininger JF, Schwartz MW: SOCS-3 expression in leptin-sensitive neurons of the hypothalamus of fed and fasted rats. Regul Pept 2000; 92: 9-15.
31. Morrison CD, White CL, Wang Z, Lee SY, Lawrence DS, Cefalu WT, Zhang ZY, Gettys TW: Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age. Endocrinology 2007; 148: 433-440.
32. Silver IA, Erecinska M: Extracellular glucose concentration in mammalian brain: Continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and hyperglycemic animals. J Neurosci 1994; 14: 5068-5076.
33. Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M, Saper CB, Scammell TE: Fos expression in orexin neurons varies with behavioral state. J Neurosci 2001; 21: 1656-1662.
34. Akiyama M, Yuasa T, Hayasaka N, Horikawa K, Sakurai T, Shibata S: Reduced food anticipatory activity in genetically orexin (hypocretin) neuron-ablated mice. Eur J Neurosci 2004; 20: 3054-3062.
35. Modirrousta M, Mainville L, Jones BE: Orexin and MCH neurons express c-Fos differently after sleep deprivation vs. recovery and bear different adrenergic receptors. Eur J Neurosci 2005; 21: 2807-2816.